Literature DB >> 1448779

Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.

J C Eikenboom1, H K Ploos van Amstel, P H Reitsma, E Briët.   

Abstract

The von Willebrand factor (vWF) genes of nine unrelated, severe, type III von Willebrand's disease (vWD) patients (six of Dutch origin) and four unrelated Dutch type I vWD patients were screened for mutations in exons that contain CGA codons (Arg), which are liable to mutation to TGA stop codons. The nine exons of the vWF gene (3, 8, 9, 10, 28, 31, 32, 43 and 45) that contain all the CGA codons (11 in total) of the vWF cDNA were amplified by the polymerase chain reaction and screened for mutations by single-strand conformation polymorphism analysis, restriction enzyme - and/or nucleotide sequence analysis. Three of the severe vWD patients were found to be heterozygous for a nonsense mutation: CGA Arg 2535-->TGA Stop. Three other severe vWD patients were homozygous for a single nucleotide substitution, AAC Asn 2546-->TAC Tyr. The transcription of these mutated alleles was tested by cDNA dependent amplification of platelet RNA. The level of transcription product was strongly reduced for either mutant allele.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448779

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay.

Authors:  Manuela Platè; Stefano Duga; Luciano Baronciani; Silvia La Marca; Valentina Rubini; Pier Mannuccio Mannucci; Augusto B Federici; Rosanna Asselta
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

2.  Seeming homozygosity in type-IIB von Willebrand's disease due to a polymorphism within the sequence of a commonly used primer.

Authors:  J C Eikenboom; P H Reitsma; E Briët
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

3.  Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.

Authors:  J C Eikenboom; T Vink; E Briët; J J Sixma; P H Reitsma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

4.  Genetic heterogeneity of severe von Willebrand disease type III in the German population.

Authors:  R Schneppenheim; S Krey; F Bergmann; D Bock; U Budde; M Lange; R Linde; U Mittler; E Meili; G Mertes
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

5.  Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I.

Authors:  P H Reitsma; H K Ploos van Amstel; R M Bertina
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.

Authors:  V Siguret; J M Lavergne; G Chérel; C Boyer-Neumann; A S Ribba; B R Bahnak; D Meyer; G Piétu
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

7.  Von Willebrand disease: an overview.

Authors:  K Pavani Bharati; U Ram Prashanth
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

8.  Multiple enzyme approach for the characterization of glycan modifications on the C-terminus of the intestinal MUC2mucin.

Authors:  Sjoerd van der Post; Kristina A Thomsson; Gunnar C Hansson
Journal:  J Proteome Res       Date:  2014-11-25       Impact factor: 4.466

9.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.